A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving
Phase 2
Completed
- Conditions
- Tobacco Use Disorder
- Registration Number
- NCT00208858
- Lead Sponsor
- Emory University
- Brief Summary
The purpose of this study is to gather pilot data to determine feasibility of and guide the development of a larger clinical trial investigating the effects of topiramate as an adjunct to nicotine replacement therapy and behavioral counseling in smoking cessation treatment. It is hypothesized that topiramate will decrease nicotine craving and result in improved outcomes for smoking cessation.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- Male, between ages of 18-55
- Meets DSM-IV criteria for nicotine dependence
- Smoke at least 20 cigarettes per day
- Motivated to quit smoking
Read More
Exclusion Criteria
- Serious or unstable medical conditions
- Current psychiatric disorder requiring medication or treatment
- Taking medication that create risk of interaction with study drug
- Current participation in another smoking cessation treatment
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Atlanta VA Medical Center
🇺🇸Decatur, Georgia, United States